loader

World Tenders & Procurement Opportunities

Czech Republic-Hradec Králové: Antineoplastic agents

World Biggest Tenders Source

This tender with title Czech Republic-Hradec Králové: Antineoplastic agents has been published on Bidding Source portal dated 31 Aug 2017 for the country of Czech Republic. It has been categorized on Antineoplastic agents. For similar tenders you can see tenders mentioned below of this page.

General Information

Czech Republic-Hradec Králové: Antineoplastic agents
Prior Information Notice
2017/S 166-341339
Czech Republic
Czech Republic-Hradec Králové
31 Aug 2017
English
Antineoplastic agents

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

557851- Czech Republic – Antineoplastic agents – Supplies of medicinal products with the active substance FLUORURACIL Czech Republic 559180-Awarded - Czech Republic – Antineoplastic agents – Drug supplies – Active substance regorafenib – ATC L01EX05 -- <b>Contract Value: 10 637 035,20 CZK</b> Czech Republic 565805- Czech Republic – Antineoplastic agents – Medicinal products containing encorafenib, binimetinib and afatinib Czech Republic 565896-Awarded - Czech Republic – Antineoplastic agents – LP s obsahem blinatumomabu 2025 -- <b>Contract Value: 12 487 237,98 CZK</b> Czech Republic 552626-Awarded - Czech Republic – Antineoplastic agents – DYNAMIC PURCHASING SYSTEM FOR ONGOING AND REPEATED PURCHASES OF MEDICINAL PRODUCTS -- <b>Contract Value: 9 360 000,00 CZK</b> Czech Republic 555956-Awarded - Czech Republic – Antineoplastic agents – Dynamic purchasing system for ongoing and repeated purchases of medicinal products Czech Republic 531271-Awarded - Czech Republic – Antineoplastic agents – Medicinal products containing pembrolizumab -- <b>Contract Value: 577 338 135,00 CZK </b> Czech Republic 523992-Awarded - Czech Republic – Antineoplastic agents – Medicinal products containing nilotinib 2025 -- <b>Contract Value: 2 231 703,00 CZK</b> Czech Republic 515195-Awarded - Czech Republic – Antineoplastic agents – Medicinal products containing eribulin mesylate -- <b>Contract Value: 2 045 916,00 CZK</b> Czech Republic 497388- Czech Republic – Antineoplastic agents – LP CONTAINING FLUORURACIL 2025 Czech Republic
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans